Table 1.
Population | The Institute of Medicine’s Recommendations [49] | The Endocrine Society Clinical Practice Guideline on Vitamin D’s Recommendations [8] | ||||
---|---|---|---|---|---|---|
Adequate Intake | Estimated Average Allowance Per Day | Recommended Daily Allowance | Daily Requirement | Upper Limit Per Day | Treatment for Vitamin D Deficiency | |
0–1 year | 400 IUs | - | - | 400–1000 IUs | 2000 IUs | 2000 IU/d or 50,000 IU/wk of vitamin D2 or D3 for at least 6 weeks to achieve serum 25(OH)D >30 ng/mL (75 nmol/L) maintenance therapy of 400–1000 IU/d |
1–18 years | - | 400 IUs | 600 IUs | 600–1000 IUs | 4000 IUs | 2000 IU/d or 50,000 IU/wk of vitamin D2 or D3 for at least 6 weeks to achieve serum 25(OH)D >30 ng/mL (75 nmol/L) maintenance therapy of 600–1000 IU/d |
18–70 years | - | 400 IUs | 600 IUs | 600–1000 IUs | 10,000 IUs | 6000 IU/d or 50,000 IU/wk of vitaminD2 or D3 for 8 weeks to achieve serum 25(OH)D >30 ng/mL (75 nmol/L) maintenance therapy of 1500–2000 IU/d |
>70 years | - | 400 IUs | 800 IUs | 1500–2000 IUs | 10,000 IUs | |
Adult patients with abnormal kinetics of vitamin D * | - | - | - | 6000–10,000 IUs | 10,000 IUs | Dosage should be increased by 2–3 times |
* Patients with abnormal kinetics of vitamin D include those with obesity or intestinal malabsorption, or those taking medications that increase the catabolism of vitamin D, including corticosteroids, antiseizures, antiretrovirals, etc.